Lyophilized vial
GLP1-SG
Long-acting GLP-1 receptor agonist analogue for metabolic pathway studies.
$160.00
3 for $320 · $106.67/vial
GLP-1 Was the Beginning. GLP-3 Expands the Research.
For Research Use Only. Not for Human Consumption.
GLP Research · Metabolic
GLP3-RT
99.91% purity · Lot K3BQAA · tested Jun 11, 2026Triple-agonist peptide studied at the GLP-1, GIP and glucagon receptors.
- Independently tested
- Lot-matched COA
- Lyophilized for stability
- Ships from the USA
Research use only. Not for human or veterinary use. Sold to qualified researchers aged 21+.
SizeTS-GLP3RT-10
$110.003 for $220 — $73.33 per vial
1
Lot-matched documentation. Every order ships with the certificate for its lot. If a vial arrives damaged or doesn't match its paperwork, tell us within 72 hours and we'll replace it.
Latest lab results
Third-party testedGLP3-RT 10 mg
- Purity (HPLC-UV)
- 99.91%
- Identity (LC-MS)
- Confirmed — GLP-3
- Net content
- 10.96 mg (label 10 mg)
- Lot
- K3BQAA
- Tested
- Jun 11, 2026
- Lab
- Freedom Diagnostics Testing
Your order ships with the certificate for its own lot. 2 earlier certificates for this size in the COA library.
About GLP3-RT
Triple-agonist peptide studied at the GLP-1, GIP and glucagon receptors.
Supplied as
10 mg per vial, as a lyophilized powder in a sealed glass vial with a crimped cap. The lot number on the label matches the certificate of analysis in the COA library.
Storage and handling
Store lyophilized powder frozen (−20 °C) or refrigerated, sealed and away from light. Once reconstituted, keep refrigerated (2–8 °C).
Handle in a laboratory setting using appropriate protective equipment. Consult the certificate of analysis and safety data for lot-specific information.
Important research notice. This product is intended solely for in-vitro and laboratory research. It is not a drug, food, supplement or cosmetic, has not been evaluated by the FDA, and must not be used in humans or animals. Thesis Scientific does not provide usage or dosing information.
Why GLP3-RT
Triple-Pathway Research
Targets GLP-1, GIP, and glucagon receptors rather than GLP-1 alone.
Broader Metabolic Signaling
Designed to investigate multiple pathways involved in energy balance and metabolic function.
Promising Clinical Research
Triple-receptor agonists like GLP3-RT are among the most closely watched compounds in metabolic research.
Next-Generation Approach
Combines three receptor mechanisms within a single investigational compound.
For Research Use Only. Not for Human Consumption.
GLP3-RT research
Beyond GLP-1: Multi-Pathway Research Starts Here.
The Next Evolution in Metabolic Research
Move beyond single-pathway GLP-1 research and investigate the potential of multi-receptor activity.
One Compound. Multiple Research Pathways.
Explore the next generation of metabolic research beyond traditional GLP-1 models.
Three Research Pathways. One Compound. A New Frontier.
More Pathways. More Research Possibilities.
Built for researchers exploring metabolic signaling beyond conventional GLP-1 models.
For Research Use Only. Not for Human Consumption.
